40
Participants
Start Date
March 31, 2015
Primary Completion Date
March 31, 2018
Study Completion Date
March 31, 2018
Octreotide
Single dose 100mcg octreotide acetate (1mL), subcutaneously to the lower abdomen
Placebo
Single dose 0.9% saline (1mL), subcutaneously to the lower abdomen
Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital, Dublin
Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg, Gothenburg
University College Dublin
OTHER
University of Dublin, Trinity College
OTHER
Göteborg University
OTHER
St. James's Hospital, Ireland
OTHER